
Alzheon’s Alzheimer’s pill fails in Phase III trial
US-based Alzheon’s Alzheimer’s disease pill has failed in a Phase III trial, but the biopharma still holds hope for the drug after seeing signals in a subgroup of patients. The company said that while valiltramiprosate did not meet the primary endpoint in …